Both AEHR and NVMI are semiconductor-adjacent names riding the artificial intelligence investment cycle, yet they sit at very different points in the value chain. Aehr Test Systems supplies specialized test and burn-in equipment used to stress chips before they ship, while Nova Ltd. provides the metrology and process-control systems manufacturers use during production. This comparison is relevant for investors weighing a high-growth, higher-risk equipment supplier against a consistently profitable process-control leader. Traders focused on momentum may gravitate toward AEHR's explosive moves, while those prioritizing profitability and steadier relative performance may find NVMI's profile more compelling. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
AEHR designs wafer-level and package-level burn-in systems that test semiconductor reliability—work increasingly tied to AI accelerators, silicon photonics, and silicon carbide power chips for electric vehicles. Recent market activity has been dramatic in both directions. The company swung to profitability in its latest quarter, reporting roughly $33 million in revenue—up about 200% year over year—and raised its fiscal 2027 outlook toward $150 million, supported by a record backlog exceeding $100 million. Despite this, the stock pulled back sharply over recent weeks, giving back a large portion of its earlier 2026 gains. Sentiment reflects a tug-of-war between strong order momentum and concerns about a premium valuation, customer concentration, and past reliance on a still-recovering EV market. From what I see, the order book looks solid but execution risks remain elevated.
NVMI supplies material, optical, and chemical metrology solutions for advanced process control in semiconductor fabrication. Its recent results have been characterized by consistency: record quarterly revenue of roughly $288 million, up about 28% year over year, alongside record profitability and a trailing-twelve-month revenue run-rate that crossed the $1 billion mark ahead of schedule. Management guided fourth-quarter revenue higher and authorized a $200 million share repurchase program, signaling confidence in the business. While the stock has also declined from its highs in recent months amid broader semiconductor multiple compression, NVMI's diversified customer base, strong free cash flow, and healthy balance sheet have supported a steadier trajectory than many peers.
The two companies occupy different niches, creating a clear trade-off for investors. AEHR is a smaller, faster-growing equipment supplier whose revenue can swing sharply with customer orders and delivery timing; its upside is tied to AI processor ramp and SiC recovery, but it carries a rich price-to-sales multiple and negative trailing earnings. NVMI is a larger, profitable process-control leader with 30%-plus operating margins, a diversified logic, memory, and foundry revenue mix, and a fortress-like cash position funding buybacks. In terms of sector exposure, AEHR is concentrated on test-and-burn-in demand, while NVMI benefits from broader wafer fab equipment spending and rising metrology intensity in advanced nodes and packaging. Risk profiles differ materially: AEHR offers higher beta and volatility, while NVMI offers steadier growth with moderating, still-elevated multiples. One thing that stands out is how NVMI's balance sheet provides more cushion during sector pullbacks.
Weighing observable factors—trend consistency, profitability, balance-sheet strength, and relative volatility—Tickeron's AI would likely favor NVMI in the current environment. Nova's record revenue, expanding margins, positive earnings, and capital-return program provide a more stable foundation than Aehr's order-driven, loss-making profile, even though AEHR's growth rate is substantially higher. The AI framework tends to reward steadier, trend-aligned performance over high-beta momentum that can reverse quickly. Consequently, NVMI appears better positioned on a risk-adjusted basis, while AEHR remains a higher-risk, higher-reward candidate best suited to investors comfortable with significant volatility. I’m watching this closely as the next earnings cycle unfolds.
When comparing names like these, I often turn to Tickeron’s AI Trading Bots to see how automated strategies are currently positioned. The platform hosts hundreds of bots with varying styles, timeframes, and performance histories, and the curated Trending AI Robots section highlights those best aligned with prevailing market conditions. This helps filter for approaches that match my own risk parameters without having to build everything from scratch. Explore the Trending AI Robots page to review the latest selections.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The 50-day moving average for AEHR moved below the 200-day moving average on November 18, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AEHR as a result. In 73 of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 86%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AEHR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Aroon Indicator for AEHR entered a downward trend on November 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where AEHR's RSI Oscillator exited the oversold zone, 26 of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The Moving Average Convergence Divergence (MACD) for AEHR just turned positive on November 03, 2026. Looking at past instances where AEHR's MACD turned positive, the stock continued to rise in 33 of 38 cases over the following month. The odds of a continued upward trend are 87%.
Following a +21.66% 3-day Advance, the price is estimated to grow further. Considering data from situations where AEHR advanced for three days, in 243 of 272 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.
The Tickeron Valuation Rating of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.970) is normal, around the industry mean (5.670). AEHR has a moderately low P/E Ratio (-232.913) as compared to the industry average of (68.795). Projected Growth (PEG Ratio) (0.927) is also within normal values, averaging (0.801). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (51.813) is also within normal values, averaging (27.897).
The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating steady price growth. AEHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 77 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AEHR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock better than average.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of burn-in and test equipment for semiconductor manufacturing
Industry ElectronicProductionEquipment